Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: The Christie hospital experience

Bone Marrow Transplantation

Volumn 32, Issue 1, 2003, Pages 73-77

  Hassan, I A ^a   Chopra, R ^b   Swindell, R ^b   Mutton, K J ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

Allogeneic; Autologous BMT SCT; Rhinovirus infection; RSV infection

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; IMMUNOGLOBULIN; RIBAVIRIN; SIALIDASE INHIBITOR;

ADULT; ALLOGRAFT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENTEROVIRUS; FEMALE; FREQUENCY ANALYSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFLUENZA VIRUS A; MALE; MORBIDITY; MORTALITY; PARAINFLUENZA VIRUS; PERIPHERAL BLOOD STEM CELL; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RHINOVIRUS; TREATMENT OUTCOME; UNITED KINGDOM; VIRUS INFECTION;

ADULT; AGED; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 0038155294     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704048     Document Type: Article

References (23)

1. Ljungman P, Ward KN, Crooks BNA et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479-484.
2. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Centre experience. Am J Med 1997; 102 (Suppl. 3a): 27-30.
3. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102: 44-48.
4. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalised adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-782.
5. Ghosh S, Champlin R, Couch R et al. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis 1999; 29: 528-532.
6. Lennette EH, Schmidt NJ (eds). Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 5th ed. APHA: Washington DC, 1979.
7. Malcolm E, Arruda E, Hayden F et al. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J Clin Virol 2001; 21: 9-16.
8. Papadopoulos N, Bates P, Bardin P et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181: 1875-1884.
9. Imakita M, Shiraki K, Yutani C et al. Pneumonia caused by rhinoviruses. Clin Infect Dis 2000; 30: 611-612.
10. Mosser AG, Brockman-Schneider R, Amineva S et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 2002; 185: 734-743
11. Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 393-399.
12. Ghosh S, Champlin RE, Englund J et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751-755.
13. DeVincenzo JP, Hirsch RL, Fuentes RJ, Top Jr FH. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in paediatric patients, undergoing bone marrow transplantation - a compassionate use experience. Bone Marrow Transplant 2000; 25: 161-165.
14. McColl MD, Corser RB, Bremner J, Chopra R. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. Bone Marrow Transplant 1998; 21: 423-425.
15. McCarthy AJ, Kingman HM, Kelly C et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 1315-1322.
16. Whimbey E, Elting LS, Couch RB et al. Influenza A virus infections among hospitalised adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437-440.
17. Robertson JD, Nagesh K, Jowitt SN et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82: 1261-1265.
18. Lewis A, Champlin R, Englund J et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996; 23:1033-1037.
19. Schmid ML, Kudesia G, Wake S, Read RC. Prospective comparative study of culture specimens and methods in diagnosing influenza in adults. BMJ 1998; 316: 275.
20. Whimbey E, Englund JA, Couch R. Community respiratory viral infections in immunocompromised patients with cancer. Am J Med 1997; 102: 10-18.
21. van Elden LJR, van Kraaij MGJ, Nijhuis M et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with haematological cancer and pneumonia. Clin Infect Dis 2002; 34: 177-183.
22. Snell NJC. New treatments for viral respiratory tract infections - opportunities and problems. J Antimicrob Chemother 2001; 47: 251-259.
23. Hsyu P-H, Pithavala YK, Gersten M et al. Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. Antimicrob Agents Chemother 2002; 46: 392-397.